壽康集團(00575.HK)旗下Deep Longevity推為醫生而設長壽醫學課程
壽康集團(00575.HK)公布,旗下Deep Longevity首個為醫生而設「長壽醫學入門」線上課程最近於英國健康數據研究所平台上推出,已獲延續醫學教育(CME)認證,由人工智能和老年科學家與執業醫師合作開發,旨在提升醫療保健專業人士的技能。
該課程由Deep Longevity的Alex Zhavoronkov博士領導的跨學科團隊發起和撰寫,課程於去年12月在公共教育平台上推出,吸引逾2,700名學者註冊。今年7月,該課程轉至Longevity Degree平台,並獲得特拉華州醫學會(MSD)的持續醫學教育認證。同年3月,長壽醫學課程的作者與英國健康數據研究所(HDR)領導合作,將課程改編並於HDR UK平台推出,是在英國及其他地區塑造新一代長壽醫生的重要一步。
長壽醫學的目標旨在利用新的可量化和量化的衰老生物標誌物,例如深度衰老時鐘,使患者的生理和心理年齡在整個生命中盡可能接近最佳的表現狀態。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.